{"disease":{"id":"pulmonary-hypertension-associated-with-hfpef","name":"pulmonary hypertension associated with hfpef"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07288398","title":"LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":540,"lead_sponsor_name":"Tenax Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03043651","title":"Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":48,"lead_sponsor_name":"United Therapeutics","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}